Search

everythinglearnresearchcommunity

for

Search:↓

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

Dermatologists should consider alpha-gal syndrome in patients with unexplained chronic skin issues.

Older patients sticking to their prostate medication saw lasting health benefits.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Four-amino acid part makes enzyme sensitive to finasteride.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Alpha-ketoglutarate protects rabbit skin cells from oxidative damage by activating a specific cell pathway.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Compounds in fluted pumpkin and African yam bean seed oils may help manage benign prostate hyperplasia.